Bausch Non Current Assets Total vs Net Debt Analysis
BHC Stock | CAD 11.95 0.10 0.84% |
Bausch Health financial indicator trend analysis is way more than just evaluating Bausch Health Companies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bausch Health Companies is a good investment. Please check the relationship between Bausch Health Non Current Assets Total and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Non Current Assets Total vs Net Debt
Non Current Assets Total vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bausch Health Companies Non Current Assets Total account and Net Debt. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Bausch Health's Non Current Assets Total and Net Debt is 0.88. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Net Debt in the same time period over historical financial statements of Bausch Health Companies, assuming nothing else is changed. The correlation between historical values of Bausch Health's Non Current Assets Total and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Bausch Health Companies are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Non Current Assets Total i.e., Bausch Health's Non Current Assets Total and Net Debt go up and down completely randomly.
Correlation Coefficient | 0.88 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Bausch Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Bausch Health's Selling General Administrative is very stable compared to the past year. As of the 29th of November 2024, Tax Provision is likely to grow to about 232.1 M, while Issuance Of Capital Stock is likely to drop 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.0B | 5.8B | 6.2B | 6.5B | Total Revenue | 8.4B | 8.1B | 8.8B | 9.2B |
Bausch Health fundamental ratios Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.9B | 31.2B | 29.2B | 25.7B | 27.4B | 14.9B | |
Short Long Term Debt Total | 25.9B | 25.2B | 22.7B | 20.8B | 22.4B | 23.5B | |
Other Current Liab | 4.3B | 4.6B | 4.6B | 2.9B | 3.0B | 3.2B | |
Total Current Liabilities | 6.2B | 4.9B | 5.2B | 3.9B | 4.3B | 4.5B | |
Total Stockholder Equity | 1.1B | 535M | (106M) | (692M) | (1.0B) | (970.9M) | |
Property Plant And Equipment Net | 1.5B | 1.6B | 1.6B | 1.6B | 1.9B | 2.0B | |
Net Debt | 22.7B | 23.3B | 22.1B | 20.2B | 21.4B | 22.5B | |
Retained Earnings | (7.5B) | (8.0B) | (9.0B) | (9.2B) | (9.8B) | (9.3B) | |
Accounts Payable | 503M | 337M | 407M | 521M | 719M | 755.0M | |
Cash | 3.2B | 605M | 582M | 564M | 947M | 502.0M | |
Non Current Assets Total | 26.9B | 25.9B | 23.6B | 21.4B | 21.8B | 12.7B | |
Non Currrent Assets Other | 411M | 664M | 340M | 326M | 2.2B | 2.3B | |
Cash And Short Term Investments | 3.2B | 605M | 582M | 564M | 947M | 505.3M | |
Net Receivables | 1.8B | 1.6B | 1.8B | 1.8B | 2.0B | 2.1B | |
Common Stock Shares Outstanding | 352.1M | 355M | 358.9M | 362.9M | 364.9M | 246.3M | |
Liabilities And Stockholders Equity | 33.9B | 31.2B | 29.2B | 25.7B | 27.4B | 14.9B | |
Non Current Liabilities Total | 26.5B | 25.7B | 24.0B | 21.5B | 23.1B | 24.3B | |
Other Current Assets | 780M | 855M | 2.3B | 803M | 1.1B | 1.2B | |
Other Stockholder Equity | 429M | 454M | 462M | 159M | 214M | 203.3M | |
Total Liab | 32.7B | 30.6B | 29.2B | 25.4B | 27.4B | 28.8B | |
Property Plant And Equipment Gross | 1.5B | 1.6B | 3.4B | 3.5B | 3.8B | 4.0B | |
Total Current Assets | 7.0B | 5.3B | 5.6B | 4.2B | 5.6B | 5.9B | |
Accumulated Other Comprehensive Income | (2.1B) | (2.1B) | (1.9B) | (2.1B) | (1.9B) | (1.8B) | |
Short Term Debt | 1.3B | 1.2B | 50M | 482M | 511M | 536.6M | |
Intangible Assets | 10.2B | 8.4B | 6.9B | 5.8B | 6.5B | 5.8B | |
Inventory | 1.1B | 1.1B | 993M | 1.1B | 1.5B | 1.6B | |
Common Stock Total Equity | 10.1B | 10.1B | 10.2B | 10.2B | 11.8B | 6.6B | |
Common Stock | 10.2B | 10.2B | 10.3B | 10.4B | 10.4B | 7.4B | |
Current Deferred Revenue | 2.7B | 167M | 2.4B | 2.1B | 2.4B | 2.5B | |
Good Will | 13.1B | 13.0B | 12.5B | 11.5B | 11.2B | 9.0B | |
Other Liab | 1.6B | 1.5B | 1.2B | 967M | 870.3M | 826.8M | |
Net Tangible Assets | (22.3B) | (21.0B) | (19.5B) | (18.0B) | (20.7B) | (21.8B) | |
Other Assets | 1.8B | 2.5B | 2.3B | 2.3B | 2.6B | 1.3B | |
Long Term Debt | 24.7B | 23.9B | 22.7B | 20.3B | 21.9B | 19.1B | |
Short Long Term Debt | 209M | 228M | 1.2B | 432M | 450M | 465.3M | |
Property Plant Equipment | 1.7B | 1.8B | 1.8B | 1.8B | 2.1B | 1.7B | |
Long Term Debt Total | 24.7B | 23.9B | 22.7B | 20.3B | 18.3B | 20.1B | |
Capital Surpluse | 429M | 454M | 462M | 159M | 143.1M | 135.9M | |
Non Current Liabilities Other | 1.1B | 1.2B | 855M | 949M | 1.0B | 805.4M |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.